retatrutide
Retatrutide Hits 2X More Targets Than Semaglutide
Retatrutide is a next-generation investigational weight-loss drug that simultaneously targets three hormonal pathways - GLP-1, GIP, and glucagon - demonstrating a mean 24.2% weight reduction in clinical trials. This multi-target approach, a significant leap from single-target drugs like semaglutide, aims to suppress appetite, improve insulin sensitivity, and increase calorie